Emergent Broadens Bioterror Offering In $125m Sanofi Smallpox Vaccine Buy

 
• By Sten Stovall
  
Smallpox
Sanofi Is Divesting Its Smallpox Vaccine To Focus On "Current and Emerging" Disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business